EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4932-4941

  Fang, Lanlan ^a,b   Cheng, Jung Chien ^b   Chang, Hsun Ming ^b   Sun, Ying Pu ^a   Leung, Peter C K ^b  

^a Reproductive Medicine Center   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; CYCLOOXYGENASE 2; EPIREGULIN; LUTEINIZING HORMONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROTEIN KINASE B;

ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; OVULATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; GRANULOSA CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUTEINIZING HORMONE; MAP KINASE SIGNALING SYSTEM; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84889824454     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2662     Document Type: Article

References (34)

1. Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol. 2002;64:69-92.
2. Armstrong DT. Prostaglandins and follicular functions. J Reprod Fertil. 1981;62:283-291.
3. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145- 182.
4. Duffy DM, Stouffer RL. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod. 2001;7:731-739.
5. Duffy DM, Stouffer RL. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod. 2002;17: 2825-2831.
6. Sogn JH, Curry TE Jr, Brännström M, et al. Inhibition of folliclestimulating hormone-induced ovulation by indomethacin in the perfused rat ovary. Biol Reprod. 1987;36:536-542.
7. Mikuni M, Pall M, Peterson CM, et al. The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol Reprod. 1998;59:1077-1083.
8. Hester KE, Harper MJ, Duffy DM. Oral administration of the cyclooxygenase- 2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primateswhenadministered to simulate emergency contraception. Hum Reprod. 2010;25:360-367.
9. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997;91:197-208.
10. Davis BJ, Lennard DE, Lee CA, et al. Anovulation in cyclooxygenase- 2-deficient mice is restored by prostaglandin E2 and interleukin- 1ß. Endocrinology. 1999;140:2685-2695.
11. Wells A. EGF receptor. Int J Biochem Cell Biol. 1999;31:637-643.
12. Harris RC, Chung E, Coffey RJ.EGFreceptor ligands. Exp Cell Res. 2003;284:2-13.
13. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127-137.
14. Schneider MR, Wolf E. The epidermal growth factor receptor and its ligands in emale reproduction: insights from rodent models. Cytokine Growth Factor Rev. 2008;19:173-181.
15. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology. 2005;146:77-84.
16. Hsieh M, Lee D, Panigone S, et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol. 2007;27:1914-1924.
17. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science. 2004;303:682-684.
18. Hsieh M, Zamah AM, Conti M. Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation. Semin Reprod Med. 2009;27:52-61.
19. Lie BL, Leung E, Leung PC, Auersperg N. Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol. 1996;120: 169-176.
20. Freimann S, Ben-Ami I, Dantes A, Ron-El R, Amsterdam A. EGFlike factor epiregulin and amphiregulin expression is regulated by gonadotropins/cAMP in human ovarian follicular cells. Biochem Biophys Res Commun. 2004;324:829-834.
21. Zamah AM, Hsieh M, Chen J, et al. Human oocyte maturation is dependent on LH-stimulated accumulation of the epidermal growth factor-like growth factor, amphiregulin. Hum Reprod. 2010;25: 2569-2578.
22. Conti M, Hsieh M, Park JY, Su YQ. Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol. 2006;20:715- 723.
23. Sirois J. Induction of prostaglandin endoperoxide synthase-2 by humanchorionic gonadotropin in bovine preovulatory follicles in vivo. Endocrinology. 1994;135:841-848.
24. Joyce IM, Pendola FL, O'Brien M, Eppig JJ. Regulation of prostaglandin- endoperoxide synthase 2 messenger ribonucleic acid expression in mouse granulosa cells during ovulation. Endocrinology. 2001;142:3187-3197.
25. Tsai EM, Chan TF, Chen YH, Hsu SC, Chuang CY, Lee JN. Mifepristone attenuates human chorionic gonadotropin-induced extracellular signal-regulated kinase 1/2 phosphorylation, cyclooxygenase- 2, and prostaglandin E2 production in human granulosa luteal cells. Fertil Steril. 2008;89:1522-1529.
26. Inoue Y, Miyamoto S, Fukami T, Shirota K, Yotsumoto F, Kawarabayashi T. Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2009; 91:1035-1041.
27. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341-354.
28. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267:1782-1788.
29. Telliez A, Furman C, Pommery N, Hénichart JP. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem. 2006;6:187-208.
30. Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase- 2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol. 2004;68:1089-1100.
31. Stern KA, Place TL, Lill NL. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate. Biochem J. 2008;410:585-594.
32. Neelam B, Richter A, Chamberlin SG, et al. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization. Biochemistry. 1998;37:4884-4891.
33. Russell DL, Robker RL. Molecular mechanisms of ovulation: coordination through the cumulus complex. Hum Reprod Update. 2007;13:289-312.
34. Fan HY, Liu Z, Shimada M, et al. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science. 2009;324:938-941.